PT3498859T - Determinação de sarcosina oxidase e peroxidase de rábano silvestre ligadas a nanopartículas de fe2o3/au através de quitosano - Google Patents

Determinação de sarcosina oxidase e peroxidase de rábano silvestre ligadas a nanopartículas de fe2o3/au através de quitosano

Info

Publication number
PT3498859T
PT3498859T PT182112011T PT18211201T PT3498859T PT 3498859 T PT3498859 T PT 3498859T PT 182112011 T PT182112011 T PT 182112011T PT 18211201 T PT18211201 T PT 18211201T PT 3498859 T PT3498859 T PT 3498859T
Authority
PT
Portugal
Prior art keywords
sarcosine
fe2o3
determination
horseradish peroxidase
nanoparticles via
Prior art date
Application number
PT182112011T
Other languages
English (en)
Original Assignee
Prevention Medicals S R O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prevention Medicals S R O filed Critical Prevention Medicals S R O
Publication of PT3498859T publication Critical patent/PT3498859T/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00—Manufacture or treatment of nanostructures
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G7/00—Compounds of gold
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/906—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
    • G01N2333/9065—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on CH-NH groups of donors (1.5)
    • G01N2333/90672—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on CH-NH groups of donors (1.5) with oxygen as acceptor (1.5.3) in general
    • G01N2333/90677—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on CH-NH groups of donors (1.5) with oxygen as acceptor (1.5.3) in general with a definite EC number (1.5.3.-)
    • G01N2333/90683—Sarcosine oxidase (1.5.3.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/12—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
    • G01N2400/24—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar beta-D-Glucans, i.e. having beta 1,n (n=3,4,6) linkages between saccharide units, e.g. xanthan
    • G01N2400/28—Chitin, chitosan

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Manufacturing & Machinery (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plasma & Fusion (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PT182112011T 2017-12-18 2018-12-10 Determinação de sarcosina oxidase e peroxidase de rábano silvestre ligadas a nanopartículas de fe2o3/au através de quitosano PT3498859T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ2017-812A CZ2017812A3 (cs) 2017-12-18 2017-12-18 Nanočástice Fe2O3/Au s navázanými enzymy sarkosin oxidázy a křenové peroxidázy pomocí chitosanu a jejich použití pro kvalitativní a kvantitativní stanovení sarkosinu v biologickém nebo environmentálním vzorku

Publications (1)

Publication Number Publication Date
PT3498859T true PT3498859T (pt) 2020-04-24

Family

ID=65033293

Family Applications (1)

Application Number Title Priority Date Filing Date
PT182112011T PT3498859T (pt) 2017-12-18 2018-12-10 Determinação de sarcosina oxidase e peroxidase de rábano silvestre ligadas a nanopartículas de fe2o3/au através de quitosano

Country Status (12)

Country Link
EP (1) EP3498859B1 (pt)
CY (1) CY1122955T1 (pt)
CZ (1) CZ2017812A3 (pt)
DK (1) DK3498859T3 (pt)
ES (1) ES2781322T3 (pt)
HR (1) HRP20200421T1 (pt)
HU (1) HUE049042T2 (pt)
LT (1) LT3498859T (pt)
PL (1) PL3498859T3 (pt)
PT (1) PT3498859T (pt)
RS (1) RS60195B1 (pt)
SI (1) SI3498859T1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113000053B (zh) * 2021-03-02 2022-09-09 广东工业大学 一种Au-Au/IrO2@Cu(PABA)级联反应器
CN113804633B (zh) * 2021-09-15 2023-07-11 中国石油大学(华东) 基于Au-Fe3O4纳米材料的沙门氏菌识别免疫探针的制备方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105695442B (zh) * 2015-12-02 2019-06-21 浙江工商大学 用于酶固定化的改性磁性壳聚糖微球、其制备方法及应用
CZ30895U1 (cs) * 2017-05-16 2017-08-08 Prevention Medicals s.r.o. Reakční směs pro kvantitativní stanovení kreatininu ve vzorku lidské moči, séra nebo plazmy
CZ30896U1 (cs) * 2017-05-16 2017-08-08 Prevention Medicals s.r.o. Reakční směs pro kvantitativní stanovení sarkosinu ve vzorku lidské moči, séra nebo plazmy
CZ30831U1 (cs) * 2017-05-16 2017-07-11 Prevention Medicals s.r.o. Diagnostický proužek pro stanovení množství sarkosinu, kreatininu a peroxidu vodíku v biologickém nebo environmentálním vzorku
CZ30902U1 (cs) * 2017-06-19 2017-08-08 Prevention Medicals s.r.o. Diagnostický proužek pro kvantitativní stanovení sarkosinu v biologickém vzorku pomocí protilátek proti sarkosinu a nanočástic zlata s peroxidázovou aktivitou nebo kvantových teček

Also Published As

Publication number Publication date
ES2781322T3 (es) 2020-09-01
RS60195B1 (sr) 2020-06-30
EP3498859A1 (en) 2019-06-19
CY1122955T1 (el) 2021-10-29
CZ307785B6 (cs) 2019-05-02
DK3498859T3 (da) 2020-03-30
LT3498859T (lt) 2020-04-27
PL3498859T3 (pl) 2020-06-29
CZ2017812A3 (cs) 2019-05-02
HRP20200421T1 (hr) 2020-06-12
EP3498859B1 (en) 2020-01-08
HUE049042T2 (hu) 2020-09-28
SI3498859T1 (sl) 2020-07-31

Similar Documents

Publication Publication Date Title
EP3558369A4 (en) ANTIBODIES SPECIFICALLY BINDING TO HUMAN IL-15 AND THEIR USES
ZA201906813B (en) Antibody binding specifically to muc1 and use thereof
IL256630B (en) Combined separator and coagulator
EP3484469A4 (en) COMPOSITIONS AND METHODS FOR THE POTENTIALIZATION OF ANTIMICROBIAL AGENTS
MX2017002085A (es) Tratamientos con nanopartículas núcleo-corteza de proteína/oligonucleótido.
EP3187189A4 (en) Composition and medicinal product for reducing body weight and body fat, and use of said product
EP3674401A4 (en) MANGANESE PEROXIDASE, CORRESPONDING GENE AND ITS USE IN THE DETOXICATION OF A MYCOTOXIN
EP3172224A4 (en) Factor h binding protein variants and methods of use thereof
EP3307283A4 (en) Composition and methods for treatment of loss of fluids leading to hypotension and/or hypovolemia
HUE049042T2 (hu) Szarkozin meghatározása Fe203/Au nanorészecskékhez kitozánnal kötött szarkozin-oxidáz és torma-peroxidáz alkalmazásával
GB202003778D0 (en) Use of lactoferrin
WO2016138312A3 (en) Antibody-mediated neutralization of marburg virus
EP3866768A4 (en) USING REBOXETINE TO TREAT NARCOLEPSY
SG11201911597YA (en) B4galt1 variants and uses thereof
EP3518898A4 (en) PREVENTION AND TREATMENT OF DIABETIC NEPHROPATHY
EP3249544A4 (en) Personal working system capable of being dynamically combined and adjusted
EP3116890A4 (en) Asymmetric interfering rna compositions that silence k-ras and methods of uses thereof
EP3702465A4 (en) CONSTRUCTION INTENDED FOR THE EXPRESSION OF A G-PROTEIN-COUPLED RECEPTOR OR A SUB-UNIT THEREOF, AND APPLICATION OF THIS CONSTRUCTION
EP3638748A4 (en) ENHANCED DESTRUCTION OF SULPHATE-REDUCING BACTERIA BY STAGED SEQUENTIAL ADDING OF OXYANION AND BIOCIDE
PL3684973T3 (pl) Kompozycja polimeru i system dodatku do polepszania wytrzymałości papieru, ich zastosowanie, oraz wytwarzanie produktów papierniczych
EP3595718A4 (en) ANTIBODIES DIRECTED AGAINST ERYTHROFERRONE AND THEIR USES
IL275493A (en) Antibodies to centrin-1, methods for their preparation and use
MY179637A (en) Adenoviral vector encoding human atonal homolog-1 (hath1)
GB201705071D0 (en) Sweat-inhibiting and/or deoderizing cosmetic agents with low emulsifier content
IL279595A (en) Aqueous liquid aptamer preparations bind to FGF2 and uses thereof